Does the classification system fit disease progression in perinatal human immunodeficiency virus infection?
The objective was to test the applicability of the new classification for paediatric human immonodeficiency virus infection. The person-time of each state, transition probabilities and survival (+/- standard errors) at 5 years, and median sojourn-time were calculated on 39 perinatally infected children followed up from the first month of life for a median of 64.5 (1.2-120.1) months. The person-times of the N2, N3, B1, C1, and C2 states were low. The transition probabilities and sojourn-times were similar for A (48.1 +/- 10.8%; 63.5 months), B (50.5 +/- 15.5%; 44.9 months) and C (74.6 +/- 15.1%; 43.1 months) clinical categories, which differed (p < 0.025) from the N category (87.9 +/- 5.5%; 12.05 months). The survival probabilities after 5 years of entering the A, B and C categories were 84.8 +/- 10.7%, 60.5 +/- 19.8% and 14.8 +/- 13.5%, respectively (p < 0.001). Immunological category 3 had lower transition probabilities and longer sojourn-times (58.8 +/- 16.6%; 53.3 months) than categories 1 (71.3 +/- 8.1%; 33.2 months) and 2 (75.6 +/- 10.5%; 19.8 months) (p < 0.01). The transition probabilities to C3 for states N3, A3 or B3 were 52.5 +/- 13.5%. In conclusion, the classification fits the clinical history better than the immunological history.
de Martino
M
M
Department of Paediatrics, University of Florence, Italy.
Zappa
M
M
Galli
L
L
Rossi
M E
ME
Vierucci
A
A
D000367:Age Factors; D018791:CD4 Lymphocyte Count; D002487:Centers for Disease Control and Prevention, U.S.; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005500:Follow-Up Studies; D015658:HIV Infections / Q000145:classification* / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality; D006801:Humans; D007223:Infant; D011379:Prognosis; D015203:Reproducibility of Results; D012720:Severity of Illness Index; D016019:Survival Analysis; D013997:Time Factors; D014481:United States